3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lymphoma
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mixed Dementias
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Lewy Body Disease
1
Kidney Neoplasms
1
Dementia, Vascular
1
Dementia
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
Filgrastim
5
fludarabine phosphate
4
Cyclophosphamide
4
Antilymphocyte Serum
4
Mycophenolic Acid
3
Carboplatin
3
pembrolizumab
2
Tacrolimus
2
Sirolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Paclitaxel
2
Methotrexate
2
Drug Therapy
2
Cyclosporine
2
Busulfan
2
valspodar
1
tremelimumab
1
thymoglobulin
1
temsirolimus
1
tanespimycin
1
sargramostim
1
poly ICLC
1
liposomal doxorubicin
1
ixabepilone
1
interferon-alfa-1b
1
glutamic acid diethyl ester
1
fludarabine
1
etoposide phosphate
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Referral and Consultation
×
Lymphoid
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts